Skip to main content
. Author manuscript; available in PMC: 2022 May 7.
Published in final edited form as: Diabetes Metab Res Rev. 2020 Apr 3;36(6):e3310. doi: 10.1002/dmrr.3310

TABLE 5.

Meta-analysis of propensity score matched analyses

95% CI
Assessment N OR/HR lo hi P < Investigators
Any statin 9043 1.27 1.14 1.41 .001 Lin et al68
Any statin 3351 1.87 1.67 2.01 .001 Mansi et al69
Any statin 6728 1.34 1.24 1.44 .001 Mansi et al51
Atorvastatin 818 1.99 1.00 3.98 .05 Park et al70
Any statin 1699 1.99 1.36 2.92 .001 Rha et al71
Any statin 1609 1.66 1.14 2.42 .001 Vande Woestijne72
Any statin 500 1.61 1.10 2.37 .001 Yamakazi73
Any statin 4610 1.26 1.12 1.41 .0001 This study
95% CI
Meta-analysis OR Lo Hi Z-value P-value
Fixed 1.33 1.29 1.37 17.842 .0001
Random 1.43 1.31 1.56 7.94 .0001
Heterogeneity
Q-value Q df P-value I-squared
26.79 6 <.0001 77.606
Tau squared SE Variance Tau
0.008 0.008 0.000 0.090